Multiparametric Characterization of Grade 2 Glioma Subtypes Using Magnetic Resonance Spectroscopic, Perfusion, and Diffusion Imaging

Article (PDF Available)inTranslational oncology 2(4):271-80 · December 2009with9 Reads
DOI: 10.1593/tlo.09178 · Source: PubMed
Abstract
The purpose of this study was to derive quantitative parameters from magnetic resonance (MR) spectroscopic, perfusion, and diffusion imaging of grade 2 gliomas according to the World Health Organization and to investigate how these multiple imaging modalities can contribute to evaluating their histologic subtypes and spatial characteristics. MR spectroscopic, perfusion, and diffusion images from 56 patients with newly diagnosed grade 2 glioma (24 oligodendrogliomas, 18 astrocytomas, and 14 oligoastrocytomas) were retrospectively studied. Metabolite intensities, relative cerebral blood volume (rCBV), and apparent diffusion coefficient (ADC) were statistically evaluated. The 75th percentile rCBV and median ADC were significantly different between oligodendrogliomas and astrocytomas (P < .0001) and between oligodendrogliomas and oligoastrocytomas (P < .001). Logistic regression analysis identified both 75th percentile rCBV and median ADC as significant variables in the differentiation of oligodendrogliomas from astrocytomas and oligoastrocytomas. Group differences in metabolite intensities were not significant, but there was a much larger variation in the volumes and maximum values of metabolic abnormalities for patients with oligodendroglioma compared with the other tumor subtypes. Perfusion and diffusion imaging provide quantitative MR parameters that can help to differentiate grade 2 oligodendrogliomas from grade 2 astrocytomas and oligoastrocytomas. The large variations in the magnitude and spatial extent of the metabolic lesions between patients and the fact that their values are not correlated with the other imaging parameters indicate that MR spectroscopic imaging may provide complementary information that is helpful in targeting therapy, evaluating residual disease, and assessing response to therapy.

Figures

Full-text (PDF)

Available from: transonc.com · License: CC BY-NC-ND
    • "The gold-standard for diagnosis of these tumours has traditionally been histology of tissue specimens obtained with biopsy. Diagnostic accuracy is limited by sampling errors and surgical accessibility, however, which can make it difficult to confirm that the histological samples are representative of the entire tumour [4,5]. "
    Full-text · Conference Paper · Oct 2015 · Biomedical Imaging and Intervention Journal
    • "With a median survival of only 14 months [7], such a delay could prove detrimental to the overall survival of the patient. Functional imaging techniques show promise for diagnosis and assessment of treatment response of patients with cancer891011. The relative cerebral blood volume (rCBV) as determined by dynamic susceptibility contrast (DSC) MRI has been shown to correlate with treatment efficacy in patients with glioma, providing a possible alternative to gross volumetric evaluation of tumor response to therapy [12,13] . "
    [Show abstract] [Hide abstract] ABSTRACT: Studies investigating dynamic susceptibility contrast magnetic resonance imaging-determined relative cerebral blood volume (rCBV) maps as a metric of treatment response assessment have generated conflicting results. We evaluated the potential of various analytical techniques to predict survival of patients with glioma treated with chemoradiation. rCBV maps were acquired in patients with high-grade gliomas at 0, 1, and 3 weeks into chemoradiation therapy. Various analytical techniques were applied to the same cohort of serial rCBV data for early assessment of survival. Three different methodologies were investigated: 1) percentage change of whole tumor statistics (i.e., mean, median, and percentiles), 2) physiological segmentation (low rCBV, medium rCBV, or high rCBV), and 3) a voxel-based approach, parametric response mapping (PRM). All analyses were performed using the same tumor contours, which were determined using contrast-enhanced T1-weighted and fluid attenuated inversion recovery images. The predictive potential of each response metric was assessed at 1-year and overall survival. PRM was the only analytical approach found to generate a response metric significantly predictive of patient 1-year survival. Time of acquisition and contour volume were not found to alter the sensitivity of the PRM approach for predicting overall survival. We have demonstrated the importance of the analytical approach in early response assessment using serial rCBV maps. The PRM analysis shows promise as a unified early and robust imaging biomarker of treatment response in patients diagnosed with high-grade gliomas.
    Full-text · Article · Dec 2013
    • "A biopsy is usually required to establish the diagnosis and subtype of a brain tumour and to plan appropriate treatment after conventional MR imaging. Advanced MR imaging modalities such as proton MR spectroscopic imaging (MRSI), perfusion-weighted imaging (PWI), and diffusion-weighted imaging (DWI) have been proposed as alternatative methods for differential diagnosis of tumours and non-tumour lesions, primary versus metastatic lesions, and tumour grading345. However, hospitals with these advanced facilities are limited and very expensive. "
    [Show abstract] [Hide abstract] ABSTRACT: Purpose: Segmentation of pathological tissues from conventional brain MRI is a difficult and time-consuming task because of the complex structure of the brain. This paper presents a novel algorithm for automatic extraction and validation of low-grade (astroctyoma) and high-grade glioma (glioblastoma) tumours, tumour boundary, white matter and grey matter from brain magnetic resonance images. Materials and methods: The pathological structures were extracted using spatial domain filtering techniques which mainly involve morphological filtering, correlation filtering and local adaptive thresholding. Axial slices of T1- FLAIR and T2-weighted MRI images of 72 patients' image datasets (glioblastoma-42; Astrocytoma-30) were used for the entire procedure. Results: A novel and robust algorithm for the extraction of definable objects such as White Matter, Grey Matter, tumour and tumour boundary by preserving its shape and grey level information was developed using spatial domain processing techniques. The results obtained were validated with the manually segmented ground truth images by considering interobserver variability and also clinically verified by an expert radiologist. The accuracy and performance of the method was evaluated by computing the Tanimoto Index, Percentage Match and Positive Prediction Value. The ranges of these parameters showed good performance with values greater than 92% in all cases. This method can eliminate partial volume effect and intensity inhomogeneities present in the image. The algorithm is a very accurate automatic segmentation method and requires low computation time. Conclusion: This method is very useful for accurate texture quantification using statistical, spectral and structural approaches, which can be used for tumour grading. This approach is also helpful for preoperative planning of surgical procedures and for evaluation of tumour growth using image registration techniques. © 2013 Biomedical Imaging and Intervention Journal. All rights reserved.
    Full-text · Article · Jan 2013
Show more